Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1431 of 5804
-
New balloon treatment shows promise for unclogging large heart arteries
Disease control CompletedThe objective of this post-market Registry is to evaluate the safety and efficacy of SELUTION SLR, a Sirolimus Drug Eluting Balloon (DEB), in treating de novo native coronary artery disease in larger vessels (≥ 2.75 mm). This is a post-market registry that collects the data of pa…
Sponsor: Wrightington, Wigan and Leigh NHS Foundation Trust • Aim: Disease control
Last updated Jun 27, 2026 08:06 UTC
-
Diabetes drug shows promise for healing hearts after attack
Disease control CompletedThis study is investigating how the medication Empagliflozin affects the heart's structure and function in patients with heart disease. Empagliflozin is already used to treat diabetes and heart conditions, and this research aims to see if it can help improve heart remodeling, whi…
Phase: PHASE2 • Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 26, 2026 16:15 UTC
-
Mind over mood: new brain training targets Depression's repetitive thoughts
Symptom relief TerminatedPatients with major depressive disorder (MDD) exhibit increased levels of rumination (i.e. repetitive thinking and focus on negative mood states) which have been found to increase the risk of depressive relapse. The ability to reduce rumination levels among these patients is grea…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Can virtual reality help curb gambling cravings?
Disease control Recruiting nowGambling disorder (GD) is recognized as an addictive disorder in the DSM-5. Craving is a core phenomenon in addiction that can lead to relapse in problem gambling for pathological gamblers. Exposure Therapy (ET) focuses on craving in addiction treatment. ET in Cognitive-Behaviora…
Phase: NA • Sponsor: University Hospital, Lille • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New Triple-Drug attack on Hard-to-Treat ovarian cancer shows promise
Disease control Recruiting nowTo learn if adding lurbinectedin to the combination of paclitaxel and bevacizumab can help to control advanced cancer.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Online prehab program aims to boost strength in liver transplant patients
Disease control Recruiting nowPhysical frailty is common in patients awaiting liver transplantation and has been associated with poor health outcomes. There is promising data from small studies showing that behavioural, nutrition, exercise therapy (prehabilitation) improves physical function in patients while…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Spit test could spot ALS early
Diagnosis OngoingRNALS is a multicentre, transversal, diagnostic and non-interventional study carried out in ALS reference centers; in order to identify a diagnostic signature for Amyotrophic Lateral Sclerosis by analyzing of coding and non-coding RNA contained in patients saliva. The study popu…
Sponsor: ZIWIG • Aim: Diagnosis
Last updated Jun 27, 2026 12:01 UTC
-
New combo immunotherapy drug enters human trials for 18 cancers
Disease control OngoingAI-061 is a co-formulation drug product (DP) consisting of 1:1 ratio mix of AI-025, an anti-PD-1 antibody, and ONC-392, an anti-CTLA-4 antibody. This is a dose escalation study to identify the maximum toxicity dose (MTD) or the recommended phase 2 dose (RP2D).
Phase: PHASE1 • Sponsor: OncoC4, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
New asthma pill shows promise in Mid-Stage trial
Disease control OngoingThe study is being conducted to evaluate the effect of 3 dosing regimens of povorcitinib on pulmonary function
Phase: PHASE2 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug shows promise for lowering bad cholesterol without statins
Disease control CompletedThe purpose of this study was to evaluate the efficacy and safety of inclisiran as a monotherapy in Chinese adults with low or moderate atherosclerotic cardiovascular disease (ASCVD) risk and elevated low-density lipoprotein cholesterol (LDL-C) who were not on any lipid lowering …
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Robotic glove could give stroke patients a hand in recovery
Symptom relief CompletedThis proposed research aims to assess the efficacy and feasibility of the EsoGLOVE in the inpatient rehabilitation setting. 1. Understanding the ability of the EsoGLOVE in providing exercise and assisting stroke patients with completing hand functional tasks, eventually improves …
Phase: NA • Sponsor: Alexandra Hospital • Aim: Symptom relief
Last updated Jul 15, 2026 00:00 UTC
-
Eye surgery showdown: which drainage device placement saves more vision cells?
Disease control Recruiting nowGlaucoma Drainage Device and Endothelial Cell Loss Compare Trial (DECLARE) is a multi-center, outcome-masked, randomized clinical trial. The purpose of this study is to compare glaucoma drainage device implantation in the anterior chamber (front part of the eye) and sulcus (small…
Phase: NA • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New study aims to close TB prevention gaps for HIV patients
Prevention OngoingTuberculosis (TB) is the world's leading infectious cause of mortality and responsible for 1/3 of deaths in people living with human immunodeficiency virus (PLHIV). Children and adolescents living with HIV (CALHIV) are disproportionately affected due to inadequate preventive serv…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 12:38 UTC
-
New crisis therapy aims to curb suicidal thoughts
Symptom relief Recruiting nowThe main objective of this project is to be able to offer a new, specific evidence-based short-term treatment method, the Suicidal Crisis Intervention (SCI), to reduce suicidality. In addition, this study aims to investigate the influence of SCI on other important aspects of suic…
Phase: NA • Sponsor: University Hospital, Ghent • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Study seeks to optimize parent training for autism in toddlers
Disease control Recruiting nowThe overarching goal of the proposed study is to: (a) determine how best to sequence two parent-mediated interventions: a social communication intervention (Project ImPACT, Improving Parents as Communication Teachers) and a disruptive behavior intervention (Parent Training for Di…
Phase: PHASE2 • Sponsor: Northwestern University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
New study tracks how sickle cell drug affects puberty and fertility
Knowledge-focused Recruiting nowThe SAFE study is a long-term research project that watches people with sickle cell anemia (SCA) over time. The main goal is to see how a medicine called hydroxyurea affects their growth, puberty, and ability to have children. A second goal is to see how hydroxyurea affects pregn…
Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:02 UTC
-
High-Tech rehab boosts independence in stroke and spinal injury patients
Symptom relief CompletedThis project will consist of 1 large clinical trial with 3 core concepts: (1) Clinical benefits of an intensive rehabilitation programme using advanced technology, compared to the control group; (2) A full health economic evaluation combined with model-based estimation of costs a…
Phase: NA • Sponsor: KU Leuven • Aim: Symptom relief
Last updated Jun 27, 2026 08:10 UTC
-
New drug aims to shrink polyps in inherited colon cancer condition
Disease control Recruiting nowThis is a multicenter, two-part trial in participants with FAP.
Phase: PHASE1, PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Stroke recovery revolution: your daily moves could shape your rehab
Knowledge-focused CompletedGoal of research program: To understand person-specific factors, such as imaging markers and activity patterns early after stroke, that may guide precision rehabilitation to optimize function and improve recovery. Objectives: 1. Test the effect of reducing sedentary behaviour e…
Phase: NA • Sponsor: University of Alberta • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
MRI-Guided brain zaps aim to ease depression
Symptom relief CompletedThe study will compare the efficacy of intermittent Theta Burst Stimulation (iTBS) with DLPFC-pgACC personalized target for major depressive disorder (MDD) and explore possible brain network mechanisms. The stimulated targets will be located by magnetic resonance imaging (MRI) ba…
Phase: PHASE2 • Sponsor: Xijing Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:25 UTC